ArticleAnnals of gastroenterological surgery2026
Functional Advantage of Central Pancreatectomy Over Distal Pancreatectomy for Benign or Low-Grade Malignant Tumors: A Comparative Analysis Based on 75-g Oral Glucose Tolerance Test.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Central pancreatectomy (CP) is a function-preserving procedure for benign or low-grade malignant lesions in the pancreatic neck or proximal body. However, endocrine function after CP has not been objectively evaluated. Methods: We retrospectively analyzed 123 patients who underwent CP ( Results: CP was associated with a higher incidence of postoperative pancreatic fistula than DP (40% vs. 8%; Conclusion: Compared with DP, which has acceptable short-term outcomes, CP preserves pancreatic endocrine function. In patients with benign or low-grade malignant pancreatic tumors with expected long-term survival, CP should be considered over DP to preserve function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.